LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 3 of total 3

Search options

  1. Article ; Online: Pretesting Discrete-Choice Experiments: A Guide for Researchers.

    Campoamor, Nicola B / Guerrini, Christi J / Brooks, Whitney Bash / Bridges, John F P / Crossnohere, Norah L

    The patient

    2024  Volume 17, Issue 2, Page(s) 109–120

    Abstract: Discrete-choice experiments (DCEs) are a frequently used method to explore the preferences of patients and other decision-makers in health. Pretesting is an essential stage in the design of a high-quality choice experiment and involves engaging with ... ...

    Abstract Discrete-choice experiments (DCEs) are a frequently used method to explore the preferences of patients and other decision-makers in health. Pretesting is an essential stage in the design of a high-quality choice experiment and involves engaging with representatives of the target population to improve the readability, presentation, and structure of the preference instrument. The goal of pretesting in DCEs is to improve the validity, reliability, and relevance of the survey, while decreasing sources of bias, burden, and error associated with preference elicitation, data collection, and interpretation of the data. Despite its value to inform DCE design, pretesting lacks documented good practices or clearly reported applied examples. The purpose of this paper is: (1) to define pretesting and describe the pretesting process specifically in the context of a DCE, (2) to present a practical guide and pretesting interview discussion template for researchers looking to conduct a rigorous pretest of a DCE, and (3) to provide an illustrative example of how these resources were operationalized to inform the design of a complex DCE aimed at eliciting tradeoffs between personal privacy and societal benefit in the context of a police method known as investigative genetic genealogy (IGG).
    MeSH term(s) Humans ; Choice Behavior ; Reproducibility of Results ; Patient Preference ; Surveys and Questionnaires
    Language English
    Publishing date 2024-02-16
    Publishing country New Zealand
    Document type Journal Article
    ZDB-ID 2466680-4
    ISSN 1178-1661 ; 1178-1653
    ISSN (online) 1178-1661
    ISSN 1178-1653
    DOI 10.1007/s40271-024-00672-z
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Assessing the Benefits and Harms Associated with Early Diagnosis from the Perspective of Parents with Multiple Children Diagnosed with Duchenne Muscular Dystrophy.

    Bhattacharyya, Oindrila / Campoamor, Nicola B / Armstrong, Niki / Freed, Megan / Schrader, Rachel / Crossnohere, Norah L / Bridges, John F P

    International journal of neonatal screening

    2024  Volume 10, Issue 2

    Abstract: Duchenne muscular dystrophy (DMD) is a rare neuromuscular disorder diagnosed in childhood. Limited newborn screening in the US often delays diagnosis. With multiple FDA-approved therapies, early diagnosis is crucial for timely treatment but may entail ... ...

    Abstract Duchenne muscular dystrophy (DMD) is a rare neuromuscular disorder diagnosed in childhood. Limited newborn screening in the US often delays diagnosis. With multiple FDA-approved therapies, early diagnosis is crucial for timely treatment but may entail other benefits and harms. Using a community-based survey, we explored how parents of siblings with DMD perceived early diagnosis of one child due to a prior child's diagnosis. We assessed parents' viewpoints across domains including diagnostic journey, treatment initiatives, service access, preparedness, parenting, emotional impact, and caregiving experience. We analyzed closed-ended responses on a -1.0 to +1.0 scale to measure the degree of harm or benefit parents perceived and analyzed open-ended responses thematically. A total of 45 parents completed the survey, with an average age of 43.5 years and 20.0% identifying as non-white. Younger siblings were diagnosed 2 years earlier on average (
    Language English
    Publishing date 2024-04-15
    Publishing country Switzerland
    Document type Journal Article
    ISSN 2409-515X
    ISSN (online) 2409-515X
    DOI 10.3390/ijns10020032
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Willingness and preferences for long-acting injectable PrEP among US men who have sex with men: a discrete choice experiment.

    Cole, Sam Wilson / Glick, Jennifer L / Campoamor, Nicola B / Sanchez, Travis H / Sarkar, Supriya / Vannappagari, Vani / Rinehart, Alex / Rawlings, Keith / Sullivan, Patrick S / Bridges, John F P

    BMJ open

    2024  Volume 14, Issue 4, Page(s) e083837

    Abstract: Introduction: Cabotegravir long-acting injectable HIV pre-exposure prophylaxis (LA-PrEP) was shown to be safe and effective in multiple clinical trials. Increasing uptake and persistence among populations with elevated risk for HIV acquisition, ... ...

    Abstract Introduction: Cabotegravir long-acting injectable HIV pre-exposure prophylaxis (LA-PrEP) was shown to be safe and effective in multiple clinical trials. Increasing uptake and persistence among populations with elevated risk for HIV acquisition, especially among men who have sex with men (MSM), is critical to HIV prevention.
    Objective: This analysis aims to understand potential users' preferences for LA-PrEP, with audience segmentation.
    Design: Willingness to use and preferences for LA-PrEP were measured in HIV-negative, sexually active MSM in the 2020 American Men's Internet Survey. Respondents answered a discrete choice experiment with paired profiles of hypothetical LA-PrEP characteristics with an opt-out option (no LA-PrEP). Conditional and mixed logit models were run; the final model was a dummy-coded mixed logit that interacted with the opt-out.
    Setting: US national online sample.
    Results: Among 2506 MSM respondents, most (75%) indicated a willingness to use LA-PrEP versus daily oral PrEP versus no PrEP. Respondents were averse to side effects and increasing costs and preferred increasing levels of protection. Respondents preferred a 2-hour time to obtain LA-PrEP vs 1 hour, with a strong aversion to 3 hours. Overall, there was an aversion to opting out of LA-PrEP, with variations: those with only one partner, no/other insurance or who were Black, Indigenous or People of Colour were significantly less likely to prefer LA-PrEP, while those who were Hispanic/Latino, college educated and <40 years significantly preferred LA-PrEP.
    Conclusions: A large proportion of MSM expressed a preference for LA-PrEP over daily oral pills. Most respondents chose LA-PrEP regardless of cost, clinic time, side effects or protection level; however, preferences varied by sociodemographics. These varied groups likely require tailored intervention strategies to achieve maximum LA-PrEP uptake and persistence.
    MeSH term(s) Humans ; Male ; Pre-Exposure Prophylaxis/methods ; Homosexuality, Male/psychology ; Adult ; HIV Infections/prevention & control ; United States ; Patient Preference/statistics & numerical data ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/therapeutic use ; Middle Aged ; Young Adult ; Patient Acceptance of Health Care/statistics & numerical data ; Surveys and Questionnaires ; Pyridones/administration & dosage ; Adolescent ; Choice Behavior ; Delayed-Action Preparations ; Injections ; Diketopiperazines
    Chemical Substances Anti-HIV Agents ; Pyridones ; cabotegravir (HMH0132Z1Q) ; Delayed-Action Preparations ; Diketopiperazines
    Language English
    Publishing date 2024-04-22
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2599832-8
    ISSN 2044-6055 ; 2044-6055
    ISSN (online) 2044-6055
    ISSN 2044-6055
    DOI 10.1136/bmjopen-2023-083837
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top